Association of Mitochondrial DNA Displacement Loop (CA)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women

Mitochondrial genome alternations may be involved in carcinogenesis. The noncoding region of the mitochondrial DNA (mtDNA) displacement loop (D-loop) has emerged as a mutational hotspot. Using data from a population-based case-control study conducted among Chinese women in Shanghai, we evaluated associations of breast cancer risk and survival with the mtDNA D-loop (CA)n dinucleotide repeat polymorphism. Included in the study were 1,058 cases and 1,129 age frequency–matched community controls that participated in the Shanghai Breast Cancer Study between 1996 and 1998. Breast cancer patients were followed to determine intervals of overall survival and disease-free survival. Overall, there was no association between the mtDNA D-loop (CA)n repeat polymorphism and breast cancer risk. Patients with multiple alleles of the mtDNA D-loop (CA)n polymorphism (heteroplasmy) had significantly poorer disease-free survival than those with one allele of the mtDNA D-loop (CA)n polymorphism (hazard ratio 1.62; 95% confidence interval, 1.16-2.26). These results suggest that the mtDNA D-loop (CA)n repeat polymorphism may be associated with breast cancer survival. Additional studies with a larger sample size are warranted. (Cancer Epidemiol Biomarkers Prev 2008;17(8):2117–22)

[1]  J. Benítez,et al.  Is mitochondrial DNA variation associated with sporadic breast cancer risk? , 2008, Cancer research.

[2]  Q. Cai,et al.  Estrogen-Induced Generation of Reactive Oxygen and Nitrogen Species, Gene Damage, and Estrogen-Dependent Cancers , 2007, Journal of toxicology and environmental health. Part B, Critical reviews.

[3]  A. Maitra,et al.  Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck , 2007, Proceedings of the National Academy of Sciences.

[4]  S. Lutz-Bonengel,et al.  Mitochondrial D-loop (CA)n repeat length heteroplasmy: frequency in a German population sample and inheritance studies in two pedigrees , 2007, International Journal of Legal Medicine.

[5]  J. Rathmell,et al.  Metabolic regulation of Akt: roles reversed , 2006, The Journal of cell biology.

[6]  Peng Huang,et al.  Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism , 2006, The Journal of cell biology.

[7]  J. Long,et al.  Genetic Polymorphisms of the CYP19A1 Gene and Breast Cancer Survival , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  A. Neugut,et al.  IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. , 2006, Carcinogenesis.

[9]  Holger Wittig,et al.  Forensic mass screening using mtDNA , 2006, International Journal of Legal Medicine.

[10]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer , 2005, Genes, chromosomes & cancer.

[11]  P. Beaune,et al.  Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  X. Shu,et al.  Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study , 2004, Breast Cancer Research.

[13]  E. Sauter,et al.  Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. , 2004, Carcinogenesis.

[14]  J. Yager,et al.  Mitochondrial localization of ER and ER in human MCF7 cells , 2004 .

[15]  X. Shu,et al.  Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. , 2004, Cancer research.

[16]  S. Toyooka,et al.  Alterations in the mitochondrial displacement loop in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Lee-Jun C Wong,et al.  Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. , 2002, Cancer research.

[18]  J. Potter,et al.  Association of body size and fat distribution with risk of breast cancer among Chinese women , 2001, International journal of cancer.

[19]  N. Bianchi,et al.  Mitochondrial genome instability in human cancers. , 2001, Mutation research.

[20]  G. Bailliet,et al.  Nuclear and mitochondrial genome instability in human breast cancer. , 2000, Cancer research.

[21]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[22]  James D. Yager,et al.  Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation , 2000 .

[23]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[24]  J. Taanman,et al.  The mitochondrial genome: structure, transcription, translation and replication. , 1999, Biochimica et biophysica acta.

[25]  S. Pollak,et al.  A third hypervariable region in the human mitochondrial D-loop. , 1997, Human genetics.

[26]  J. Carpten,et al.  Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. , 1996, BioTechniques.

[27]  H. Joenje,et al.  Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. , 1992, Mutation research.

[28]  G. Kroemer,et al.  The mitochondrion in apoptosis: how Pandora's box opens , 2001, Nature Reviews Molecular Cell Biology.

[29]  J. Yager,et al.  Endogenous estrogens as carcinogens through metabolic activation. , 2000, Journal of the National Cancer Institute. Monographs.

[30]  R. Szibor,et al.  Mitochondrial D‐loop 3′ (CA)n repeat polymorphism: Optimization of analysis and population data , 1997, Electrophoresis.